Stille Valuation

Is STIL undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of STIL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: STIL (SEK218) is trading below our estimate of fair value (SEK440.2)

Significantly Below Fair Value: STIL is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for STIL?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for STIL. This is calculated by dividing STIL's market cap by their current preferred multiple.
What is STIL's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	SEK 1.96b

STIL key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	4.3x
Enterprise Value/EBITDA	20.2x
PEG Ratio	1.2x

Price to Earnings Ratio vs Peers

How does STIL's PE Ratio compare to its peers?

The above table shows the PE ratio for STIL vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	47.5x
CRAD B C-Rad	25.5x	33.9%	SEK 1.4b
ADDV A ADDvise Group	21.8x	15.4%	SEK 1.4b
PAX Paxman	38.5x	50.6%	SEK 1.1b
ELOS B Elos Medtech	104.3x	n/a	SEK 5.7b
STIL Stille	40.9x	34.4%	SEK 2.0b

Price-To-Earnings vs Peers: STIL is good value based on its Price-To-Earnings Ratio (40.9x) compared to the peer average (47.5x).

Price to Earnings Ratio vs Industry

How does STIL's PE Ratio compare vs other companies in the European Medical Equipment Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	26.1%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	26.1%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: STIL is expensive based on its Price-To-Earnings Ratio (40.9x) compared to the European Medical Equipment industry average (29.9x).

Price to Earnings Ratio vs Fair Ratio

What is STIL's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

STIL PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	40.9x
Fair PE Ratio	25.3x

Price-To-Earnings vs Fair Ratio: STIL is expensive based on its Price-To-Earnings Ratio (40.9x) compared to the estimated Fair Price-To-Earnings Ratio (25.3x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst STIL forecast and predictions for the stock price in 12 month’s time.
Date	Share Price	Average 1Y Price Target	Dispersion	High	Low	1Y Actual price	Analysts
Current	SEK 218.00	SEK 270.50 +24.1%	3.5%	SEK 280.00	SEK 261.00	n/a	2
Sep ’25	SEK 209.00	SEK 270.50 +29.4%	3.5%	SEK 280.00	SEK 261.00	n/a	2
Aug ’25	SEK 236.00	SEK 270.50 +14.6%	3.5%	SEK 280.00	SEK 261.00	n/a	2
Jul ’25	SEK 214.00	SEK 231.50 +8.2%	12.3%	SEK 260.00	SEK 203.00	n/a	2

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.